Topic Editors

iBB-Institute for Bioengineering and Biosciences and i4HB-Institute for Health and Bioeconomy, Instituto Superior Técnico, Av. Rovisco Pais, 1049-001 Lisboa, Portugal
IBB—Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal

Antimicrobial Agents and Nanomaterials—2nd Edition

Abstract submission deadline
31 October 2026
Manuscript submission deadline
31 December 2026
Viewed by
478

Topic Information

Dear Colleagues,

Antimicrobial resistance (AMR) has come to represent a major problem that has been demonstrated across healthcare settings worldwide. AMR is caused by multidrug-resistant (MDR) microorganisms, or “superbugs”, which can evade many of the antibiotics used in clinical practice. Today, MDR microorganisms constitute a great clinical and economic burden. In fact, the current methods of clinical treatment have started to rely on more aggressive antibiotic therapy, leading to a decrease in the life quality of the infected patients and an increase in the associated therapeutic costs. Due to the failure of conventional antibiotics, we are now entering a new era of clinical treatment based on compounds. This is reflected, for example, in the development of antibacterial nanomaterials or nanoantibiotics. This Topic aims to identify the novel strategies that may be used to overcome AMR, with a particular focus on the development of medical nanomaterials. Topics of interest include, but are not limited to, the following:

  • Antimicrobial polymers;
  • Antimicrobial peptides and peptidomimetics;
  • Synergic effects of antimicrobial agents;
  • Antimicrobial coatings;
  • Inhibitors of virulence factors;
  • Drug nanodelivery systems.

We welcome the contributions of authors working in this critical field of research.

Prof. Dr. Vasco D. B. Bonifácio
Dr. Sandra Pinto
Topic Editors

Keywords

  • multidrug-resistant bacteria (MDR)
  • resistance mechanisms
  • antibiotics
  • novel antimicrobial agents
  • drug susceptibility

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Biomolecules
biomolecules
4.8 9.4 2011 18.4 Days CHF 2700 Submit
International Journal of Molecular Sciences
ijms
4.9 8.1 2000 16.8 Days CHF 2900 Submit
Micro
micro
- - 2021 24.5 Days CHF 1000 Submit
Molecules
molecules
4.2 7.4 1996 15.1 Days CHF 2700 Submit
Antibiotics
antibiotics
4.3 7.3 2012 15.8 Days CHF 2900 Submit
Nanomaterials
nanomaterials
4.4 8.5 2010 14.1 Days CHF 2400 Submit
Microorganisms
microorganisms
4.1 7.4 2013 11.7 Days CHF 2700 Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers

This Topic is now open for submission.
Back to TopTop